Combining Anti-Angiogenic Therapy with Immunotherapy and Chemotherapy for Lung Cancer
Author Information
Author(s): Abdallah Mahmoud, Voland Rick, Decamp Malcolm, Flickinger John, Pacioles Toni, Jamil Muhammad, Silbermins Damian, Shenouda Mina, Valsecchi Matias, Bir Arvinder, Shweihat Yousef, Bastidas Juan, Chowdhury Nepal, Kachynski Yury, Eldib Howide, Wright Thomas, Mahdi Ahmad, Al-Nusair Jowan, Nwanwene Kemnasom, Varlotto John
Primary Institution: Department of Oncology, Edwards Comprehensive Cancer Institute, Marshall University, Huntington, WV, USA
Hypothesis
Can combining anti-angiogenic therapy with immunotherapy and chemotherapy improve outcomes for patients with non-small-cell lung cancer?
Conclusion
The combination of anti-angiogenic therapy, immunotherapy, and chemotherapy may enhance treatment efficacy and improve survival rates in patients with non-small-cell lung cancer.
Supporting Evidence
- Anti-angiogenic therapy can improve the effectiveness of immunotherapy.
- Combining therapies may lead to better survival rates in patients with difficult-to-treat mutations.
- Clinical trials show significant benefits in progression-free survival with combined treatment approaches.
Takeaway
This study looks at how mixing different cancer treatments can help people with lung cancer live longer and feel better.
Methodology
The article reviews recent literature and clinical trials on the combination of anti-angiogenic therapy, immunotherapy, and chemotherapy for treating non-small-cell lung cancer.
Potential Biases
Potential biases in trial designs and patient selection may affect the outcomes.
Limitations
The review is based on existing literature and may not include all recent studies or data.
Participant Demographics
The study includes patients with locally advanced and metastatic non-small-cell lung cancer, including those with specific genetic mutations.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website